Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma

Osteosarcoma is the most prevalent primary bone malignancy. Due to its high aggressiveness, novel treatment strategies are urgently required to improve survival of patients with osteosarcoma, especially those with advanced disease. Desmopressin (dDAVP) is a widely used blood-saving agent that has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobol, Natasha Tatiana, Solernó, Luisina María, Beltrán, Brady, Vásquez, Liliana, Ripoll, Giselle Vanina, Garona, Juan, Alonso, Daniel Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027742/
https://www.ncbi.nlm.nih.gov/pubmed/33850538
http://dx.doi.org/10.3892/etm.2021.9998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027742/
https://www.ncbi.nlm.nih.gov/pubmed/33850538
http://dx.doi.org/10.3892/etm.2021.9998

Ejemplares similares